Enhanced Diabetes Management Program for Type 2 Diabetes
(FREEDOM Trial)
Trial Summary
What is the purpose of this trial?
Brief Summary: The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adults in the Deep South. The intervention targets social determinants of health (SDoH) such as reduced healthcare access, poverty, transportation barriers, and food insecurity.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, ongoing insulin treatment is required, and if you are part of the HIV cohort, you must continue your prescribed HIV ART therapy.
What data supports the effectiveness of this treatment for managing Type 2 Diabetes?
Research shows that diabetes self-management education and support (DSMES) programs can improve health outcomes, such as reducing weight and blood sugar levels, and decrease emergency visits. Digital tools and community-based programs have been effective in extending these benefits and supporting lifestyle changes.12345
Is the Enhanced Diabetes Management Program for Type 2 Diabetes safe for humans?
How is the Enhanced Diabetes Management Program for Type 2 Diabetes different from other treatments?
The Enhanced Diabetes Management Program is unique because it combines Diabetes Self-Management Education and Support (DSMES) with digital health coaching, food box delivery, and remote patient monitoring (RPM), offering a comprehensive approach that integrates education, nutrition, and technology to support patients in managing their diabetes more effectively.357910
Research Team
Eligibility Criteria
The FREEDOM study is for low-income Black adults in the Deep South with type 2 diabetes, aged 18 or older, who are HIV positive and on insulin treatment. Participants must have a high HbA1c level indicating poor blood sugar control and face social challenges like poverty. They can't join if they're pregnant, planning to become pregnant soon, have severe kidney disease or cognitive issues, or are already in another diabetes study.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive digital health coaching, food box delivery, and remote patient monitoring for diabetes management
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Core Intervention: Diabetes Self-Management Education and Support (DSMES) Program (Behavioral Intervention)
- Digital Health Coaching (Behavioral Intervention)
- Food Box Delivery (Dietary Supplement)
- Remote Patient Monitoring (RPM) (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Kierstin Kennedy
University of Alabama at Birmingham
Chief Medical Officer since 2022
MD
S. Dawn Bulgarella
University of Alabama at Birmingham
Chief Executive Officer since 2023
BSc in Commerce and Business Administration from the University of Alabama, MS in Health Administration from the University of Alabama at Birmingham
Cooper Green Mercy Health Services
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Dr. Eliseo J. Pérez-Stable
National Institute on Minority Health and Health Disparities (NIMHD)
Chief Executive Officer since 2015
MD from University of Miami
Dr. Rada Dagher
National Institute on Minority Health and Health Disparities (NIMHD)
Chief Medical Officer since 2024
MD from University of California, San Francisco
Pack Health
Industry Sponsor
University of Mississippi Medical Center
Collaborator
Dodie T. McElmurray
University of Mississippi Medical Center
Chief Executive Officer since 2024
BS in Nursing from Delta State University, MSN/MBA from University of Phoenix
Dr. LouAnn Woodward
University of Mississippi Medical Center
Chief Medical Officer since 2015
MD from University of Mississippi Medical Center
Cooper Green Mercy Health Systems
Collaborator